Carboxypeptidase type II (prostate-specific membrane antigen—PSMA) is a transmembrane protein that is not only expressed on the surface of prostate cancer cells but also in neovascular endothelial cells of various solid malignancies, including RCC [8,9]. This evidence concerns the gene FOLH1 and renal cell carcinoma.